Cargando…

The Interplay between GSK3β and Tau Ser262 Phosphorylation during the Progression of Tau Pathology

Tau hyperphosphorylation has been linked directly to the formation of toxic neurofibrillary tangles (NFTs) in tauopathies, however, prior to NFT formation, the sequence of pathological events involving tau phosphorylation remains unclear. Here, the effect of glycogen synthase kinase 3β (GSK3β) on ta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Liqing, Oseid, Daniel E., Wells, Evan A., Robinson, Anne Skaja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569960/ https://www.ncbi.nlm.nih.gov/pubmed/36232909 http://dx.doi.org/10.3390/ijms231911610

Ejemplares similares

Critical Molecular and Cellular Contributors to Tau Pathology
por: Song, Liqing, et al.
Publicado: (2021)

The Cellular Distribution and Ser262 Phosphorylation of Tau Protein Are Regulated by BDNF In Vitro
por: Chen, Qian, et al.
Publicado: (2014)

Stabilization of Microtubule-Unbound Tau via Tau Phosphorylation at Ser262/356 by Par-1/MARK Contributes to Augmentation of AD-Related Phosphorylation and Aβ42-Induced Tau Toxicity
por: Ando, Kanae, et al.
Publicado: (2016)

Heparan Sulfate Proteoglycans (HSPGs) Serve as the Mediator Between Monomeric Tau and Its Subsequent Intracellular ERK1/2 Pathway Activation
por: Song, Liqing, et al.
Publicado: (2022)

DHCR24 Knock-Down Induced Tau Hyperphosphorylation at Thr181, Ser199, Thr231, Ser262, Ser396 Epitopes and Inhibition of Autophagy by Overactivation of GSK3β/mTOR Signaling
por: Bai, Xiaojing, et al.
Publicado: (2021)

Tau Phosphorylation by GSK3 in Different Conditions
por: Avila, Jesús, et al.
Publicado: (2012)

Overexpression of 14-3-3ζ Promotes Tau Phosphorylation at Ser(262) and Accelerates Proteosomal Degradation of Synaptophysin in Rat Primary Hippocampal Neurons
por: Qureshi, Hamid Y., et al.
Publicado: (2013)

Correction: Overexpression of 14-3-3ζ Promotes Tau Phosphorylation at Ser(262) and Accelerates Proteosomal Degradation of Synaptophysin in Rat Primary Hippocampal Neurons
Publicado: (2014)

Tau phosphorylation by GSK-3β promotes tangle-like filament morphology
por: Rankin, Carolyn A, et al.
Publicado: (2007)

Hsp90 Maintains the Stability and Function of the Tau Phosphorylating Kinase GSK3β
por: Dou, Fei, et al.
Publicado: (2007)

GSK-3β phosphorylation of functionally distinct tau isoforms has differential, but mild effects
por: Voss, Kellen, et al.
Publicado: (2009)

Modification of the Drosophila model of in vivo Tau toxicity reveals protective phosphorylation by GSK3β
por: Povellato, Giulia, et al.
Publicado: (2013)

The impact of tau hyperphosphorylation at Ser(262) on memory and learning after global brain ischaemia in a rat model of reversible cardiac arrest
por: Majd, Shohreh, et al.
Publicado: (2016)

Salidroside reduces tau hyperphosphorylation via up-regulating GSK-3β phosphorylation in a tau transgenic Drosophila model of Alzheimer’s disease
por: Zhang, Bei, et al.
Publicado: (2016)

Modulation of GSK-3 as a Therapeutic Strategy on Tau Pathologies
por: Medina, Miguel, et al.
Publicado: (2011)

Phosphorylation at Ser289 Enhances the Oligomerization of Tau Repeat R2
por: Man, Viet Hoang, et al.
Publicado: (2023)

AMP-activated protein kinase modulates tau phosphorylation and tau pathology in vivo
por: Domise, Manon, et al.
Publicado: (2016)

Tau aggregation and its interplay with amyloid-β
por: Nisbet, Rebecca M., et al.
Publicado: (2014)

Physiological and pathological phosphorylation of tau by Cdk5
por: Kimura, Taeko, et al.
Publicado: (2014)

GSK3β Inhibition by Phosphorylation at Ser(389) Controls Neuroinflammation
por: Calvo, Belen, et al.
Publicado: (2022)

GSK3β and Tau Protein in Alzheimer’s Disease and Epilepsy
por: Toral-Rios, Danira, et al.
Publicado: (2020)

Dissociation of tau toxicity and phosphorylation: role of GSK-3β, MARK and Cdk5 in a Drosophila model
por: Chatterjee, Shreyasi, et al.
Publicado: (2009)

Oral (−)-Epicatechin Inhibits Progressive Tau Pathology in rTg4510 Mice Independent of Direct Actions at GSK3β
por: Hole, Katriona L., et al.
Publicado: (2021)

Assessment of tau phosphorylation and β‐amyloid pathology in human drug‐resistant epilepsy
por: Aroor, Alisha, et al.
Publicado: (2023)

Probiotic supplement as a promising strategy in early tau pathology prevention: Focusing on GSK-3β?
por: Flynn, Cassandra M., et al.
Publicado: (2023)

Specific binding of Hsp27 and phosphorylated Tau mitigates abnormal Tau aggregation-induced pathology
por: Zhang, Shengnan, et al.
Publicado: (2022)

Selective inhibition of phosphodiesterase 4D increases tau phosphorylation at Ser214 residue
por: Villa, Viviana, et al.
Publicado: (2022)

Melatonin Reduces GSK3β-Mediated Tau Phosphorylation, Enhances Nrf2 Nuclear Translocation and Anti-Inflammation
por: Das, Rashmi, et al.
Publicado: (2020)

CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer’s disease
por: Barthélemy, Nicolas R., et al.
Publicado: (2023)

Overexpression of GSK-3β in Adult Tet-OFF GSK-3β Transgenic Mice, and Not During Embryonic or Postnatal Development, Induces Tau Phosphorylation, Neurodegeneration and Learning Deficits
por: Rodríguez-Matellán, Alberto, et al.
Publicado: (2020)

Tau passive immunization inhibits not only tau but also Aβ pathology
por: Dai, Chun-ling, et al.
Publicado: (2017)

Rapamycin Attenuates the Progression of Tau Pathology in P301S Tau Transgenic Mice
por: Ozcelik, Sefika, et al.
Publicado: (2013)

Cholesterol Dependent Activity of the Adenosine A(2A) Receptor Is Modulated via the Cholesterol Consensus Motif
por: McGraw, Claire, et al.
Publicado: (2022)

Extracellular α-Synuclein Leads to Microtubule Destabilization via GSK-3β-Dependent Tau Phosphorylation in PC12 Cells
por: Gąssowska, Magdalena, et al.
Publicado: (2014)

Absence of a Role for Phosphorylation in the Tau Pathology of Alzheimer’s Disease
por: Lai, Robert Y. K., et al.
Publicado: (2016)

Pathologic Thr(175) tau phosphorylation in CTE and CTE with ALS
por: Moszczynski, Alexander J., et al.
Publicado: (2018)

Convergence of Amyloid-β and Tau Pathologies on Mitochondria In Vivo
por: Eckert, Anne, et al.
Publicado: (2010)

Biomarkers for tau pathology
por: Schöll, Michael, et al.
Publicado: (2019)

In-Cell NMR Study of Tau and MARK2 Phosphorylated Tau
por: Zhang, Shengnan, et al.
Publicado: (2018)

Enhancement of therapeutic potential of a naturally occurring human antibody targeting a phosphorylated Ser(422) containing epitope on pathological tau
por: van Ameijde, Jeroen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3e0t1trvfa8372ca9enga6koo1